1. Aims and Scope

Xenobiotica covers three main areas: general xenobiochemistry, including the metabolism and disposition of drugs and environmental chemicals in animals, plants and micro-organisms, and the related methodology; molecular toxicology, concerning mechanisms of toxicity and the study of toxicology at the molecular level; and clinical pharmacokinetics and metabolism, focusing on the pharmacokinetic behaviour of foreign compounds in man. A close liaison between Xenobiotica and the International Society for the Study of Xenobiotics has been established, giving rise to special issues of the journal.

Further information about the Journal, including links to the online sample copy and contents pages, can be found on the Journal homepage.

2. Editor-in-Chief

Prof. G.G. Gibson

School of Biomedical and Molecular Sciences
University of Surrey
Guildford
Surrey
GU2 7XH
United Kingdom

Please click here for the full Editorial Board.

3. Submission of Manuscripts

All submissions should be made online at Xenobiotica's Manuscript Central site. New users should first create an account. Once a user is logged onto the site submissions should be made via the Author Centre.

Manuscripts must be submitted in Microsoft Word format (.doc files) and consist of the complete submission in the order of text, Tables (with legends/footnotes), a separate list of figure legends and the figures themselves. Tables should be submitted in tabulated format, having been created in Microsoft Word. Do not imbed the Tables and Figures into the text. If problems occur during submission, then contact the Editor-in-Chief, Professor Gibson, at g.gibson@surrey.ac.uk.

Please make sure your contact address information is clearly visible on the outside of all packages you are sending to the Editor.

4. Preparation of Manuscripts

Xenobiotica considers all manuscripts on the strict condition that they have been submitted only to Xenobiotica, that they have not been published already, nor are they under consideration for publication or in press elsewhere. Authors who fail to adhere to this condition will be charged with all costs that Xenobiotica incurs and their papers will not be published.

Research article contributions to Xenobiotica must report original research and all manuscripts will be subjected to review by referees. The following guidelines apply:

• For all manuscripts non-discriminatory language is mandatory. Sexist or racist terms should not be used.
• Each paper should have three to six keywords.
• Papers are accepted only in English.
• Manuscripts for hard-copy submission should be typed on single sides of good quality white A4 or 8 x 11 inch paper, double-spaced throughout including the reference section, with wide (3 cm) margins.
• All the authors of a paper should include their full names, affiliations, postal addresses, telephone and fax numbers and email addresses on the cover page of manuscripts.
• Abstracts of 100-150 words, sub-divided into numbered paragraphs, are required for all papers submitted and should precede the text of a paper - see Notes on Style.
• Manuscripts should be compiled in the following order: title page; abstract; keywords; main text; acknowledgments; appendixes (as appropriate); references; table(s) with caption(s) (on individual sheets); figure caption(s) (as a list).
• Section headings should be concise and numbered sequentially, using a decimal system for subsections.
• Authors must adhere to SI units.
• For information on submitting animations, movie files and sound files or any additional information including indexes and calendars please click here.
• When using a word which is or is asserted to be a proprietary term or trade mark authors must use the symbol ® or ™ or alternatively a footnote can be inserted using the wording below:
• This article includes a word that is or is asserted to be a proprietary term or trade mark. Its inclusion does not imply it has acquired for legal purposes a non-proprietary or general significance, nor is any other judgement implied concerning its legal status.

5. Ethics and Consent

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients' names, initials, or hospital numbers, especially in illustrative material. Papers including animal experiments or clinical trials must be conducted with approval by the local animal care or human subject committees, respectively.

Identifying information should not be published in written descriptions, photographs, and pedigrees, unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published.

6. Declaration of Interest

It is the policy of all Informa Healthcare, to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE). (http://www.icmje.org/index.html#conflict)

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organisation with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.

All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading "Declaration of interest" and where available within the appropriate field on the journal's Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.

If no conflict is declared, the following statement will be attached to all articles:

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgements on conclusions drawn. 

7. Authorship Contributions

Contributions must be substantial in order to warrant authorship. Each author should have participated sufficiently in the work to take public responsibility for the content. All other contributors should be listed as acknowledgements.

8. Colour Charges

There are a limited number of colour pages within the annual page allowance. Authors should restrict their use of colour to situations where it is necessary on scientific, and not merely cosmetic, grounds. In addition, authors may pay to publish colour illustrations, but please consult the publisher regarding cost before submission.

There are no charges for non-colour pages.

9. Proofs

The Editor reserves the right to proceed to press without submitting page proofs to the author. However, usual practice will involve corresponding authors receiving email notification with a password and Web address from which to download a PDF. Hard copies of proofs will not be mailed. To avoid delays in publication, corrections to proofs must be returned within 48 hours, by electronic transmittal, fax or mail. Authors will be charged for excessive correction at this stage of production.

If authors do not return page proofs promptly, the Editor reserves the choice to either delay publication to a subsequent issue or to proceed to press without author corrections.

10. Offprints and Reprints

Offprints and reprints of articles published in Xenobiotica can be purchased once the article has been published online. You will be given the opportunity to order offprints and/or reprints via Rightslink® at the time at which you receive proofs of your article. Copies of the Journal can be purchased at the authors' preferential rate of £15.00/$25.00 per copy.

11. Copyright

It is a condition of publication that authors assign copyright or license the publication rights in their articles, including abstracts, to Informa UK Ltd. This enables us to ensure full copyright protection and to disseminate the article, and the Journal, to the widest possible readership in print and electronic formats as appropriate. Authors may, of course, use the article elsewhere after publication without prior permission from Informa UK Ltd., provided that acknowledgement is given to the Journal as the original source of publication, and that Informa Healthcare is notified so that our records show that its use is properly authorised. Authors retain a number of other rights under the Informa UK Ltd. rights policies documents. These policies are referred to at the Copyright FAQs page.

Authors are themselves responsible for obtaining permission to reproduce copyright material from other sources. See Copyright Permission for full details.

A copyright agreement form can be downloaded by corresponding authors of accepted manuscripts with proofs. This should be signed and returned to Taylor & Francis.

Xenobiotica
Informa Healthcare
5th Floor
Telephone House
69-77 Paul Street
London
EC2A 4LQ, UK
Tel: (+44) 207 017 7659
Fax: (+44) 207 017 6914